mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.4 |